The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential
Nobutake Yamamichi(The University of Tokyo), Hideo Iba(Chiba University), Taketoshi Mizutani(Tokyo University of Science), Nao Kobayashi(Tokyo University of Science), Naohisa Yahagi(Keio University), Mitsue Yamamichi-Nishina(Tokyo University of Science), Taiji Ito(Tokyo University of Science), Hirotaka Watanabe(Nagoya University), Masao Ichinose(Wakayama Medical University), Shigeru Minoguchi(Kurume University), Satoko Kimura(Tokyo University of Science), Masao Omata(University of Yamanashi Hospital)
Cited by 102
Related Papers
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
|Hepatology International|2017|2.2k
Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer
|Digestive Endoscopy|2015|575
Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition)
|Digestive Endoscopy|2020|510
Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment
|Digestive Endoscopy|2013|469
Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms
|Gastrointestinal Endoscopy|2009|436